In the setting of deregulated MYC, samples with ID3 mutations show a higher level of expression of known MYC target genes, and give rise to increased G1-to-S-phase cell-cycle progression in BL, suggesting a role for ID3 as a tumor suppressor in this type of lymphoma [129]. The gene discussed is MYC; the disease is Burkitt lymphoma.